BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 29193840)

  • 1. Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study.
    Schulman E; Bartlett SJ; Schieir O; Andersen KM; Boire G; Pope JE; Hitchon C; Jamal S; Thorne JC; Tin D; Keystone EC; Haraoui B; Goodman SM; Bykerk VP;
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1185-1191. PubMed ID: 29193840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.
    Sandberg ME; Bengtsson C; Källberg H; Wesley A; Klareskog L; Alfredsson L; Saevarsdottir S
    Ann Rheum Dis; 2014 Nov; 73(11):2029-33. PubMed ID: 24818635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis.
    Eder L; Thavaneswaran A; Chandran V; Cook RJ; Gladman DD
    Ann Rheum Dis; 2015 May; 74(5):813-7. PubMed ID: 24431392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index and response to abatacept in rheumatoid arthritis.
    Gardette A; Ottaviani S; Sellam J; Berenbaum F; Lioté F; Fautrel B; Palazzo E; Meyer A; Sibilia J; Dieudé P
    Eur J Clin Invest; 2016 Dec; 46(12):1048-1052. PubMed ID: 27736006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study.
    Mariette X; Alten R; Nüßlein HG; Galeazzi M; Lorenz HM; Cantagrel A; Chartier M; Poncet C; Rauch C; Le Bars M
    Joint Bone Spine; 2017 Oct; 84(5):571-576. PubMed ID: 28043761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).
    Iannone F; Courvoisier DS; Gottenberg JE; Hernandez MV; Lie E; Canhão H; Pavelka K; Hetland ML; Turesson C; Mariette X; Choquette D; Finckh A
    Clin Rheumatol; 2017 Apr; 36(4):773-779. PubMed ID: 27966068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body Mass Index Impact on Disease Activity, Clinical and Sonographic Remission Rates in Patients with Rheumatoid Arthritis.
    Sapundzhieva T; Karalilova R; Batalov A
    Curr Rheumatol Rev; 2019; 15(3):215-223. PubMed ID: 30499417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index as a driver of selection of biologic therapy in rheumatoid arthritis. Results from the US-CLARA study.
    Di Carlo M; Salaffi F; Gremese E; Iannone F; Lapadula G; Ferraccioli G;
    Eur J Intern Med; 2019 Aug; 66():57-61. PubMed ID: 31113709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH).
    Kuriya B; Xiong J; Boire G; Haraoui B; Hitchon C; Pope J; Thorne JC; Tin D; Keystone EC; Bykerk V;
    J Rheumatol; 2014 Nov; 41(11):2161-6. PubMed ID: 25274902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No predictive effect of body mass index on clinical response in patients with rheumatoid arthritis after 24 weeks of biological disease-modifying antirheumatic drugs: a single-center study.
    Kim SK; Choe JY; Park SH; Lee H
    Clin Rheumatol; 2016 May; 35(5):1129-36. PubMed ID: 26932795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort.
    Arnold MB; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
    Rheumatology (Oxford); 2014 Jun; 53(6):1075-86. PubMed ID: 24501240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study.
    Gardette A; Ottaviani S; Sellam J; Berenbaum F; Lioté F; Meyer A; Sibilia J; Fautrel B; Palazzo E; Dieudé P
    Clin Rheumatol; 2016 Apr; 35(4):857-61. PubMed ID: 26801332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal: A Prospective Observational Cohort Study from Southern Sweden.
    Einarsson JT; Geborek P; Saxne T; Kristensen LE; Kapetanovic MC
    J Rheumatol; 2016 Jun; 43(6):1017-23. PubMed ID: 27036384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
    Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
    Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and treatment survival in patients with RA starting treatment with TNFα-inhibitors: long-term follow-up in the real-life METEOR registry.
    Bergstra SA; Allaart CF; Vega-Morales D; De Buck M; Murphy E; Salomon Escoto K; Huizinga TWJ
    RMD Open; 2020 Jun; 6(2):. PubMed ID: 32506054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms.
    Ajeganova S; van Steenbergen HW; van Nies JA; Burgers LE; Huizinga TW; van der Helm-van Mil AH
    Ann Rheum Dis; 2016 May; 75(5):867-73. PubMed ID: 25972519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained clinical remission of rheumatoid arthritis and its predictive factors in an unselected adult Chinese population from 2009 to 2018.
    Xie W; Li J; Zhang X; Sun X; Zhang Z
    Int J Rheum Dis; 2019 Sep; 22(9):1670-1678. PubMed ID: 31297977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index and response to infliximab in rheumatoid arthritis.
    Ottaviani S; Gardette A; Tubach F; Roy C; Palazzo E; Gill G; Meyer O; Dieudé P
    Clin Exp Rheumatol; 2015; 33(4):478-83. PubMed ID: 25962513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients.
    Jawaheer D; Messing S; Reed G; Ranganath VK; Kremer JM; Louie JS; Khanna D; Greenberg JD; Furst DE
    Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1811-8. PubMed ID: 22730408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases.
    Albrecht K; Richter A; Callhoff J; Huscher D; Schett G; Strangfeld A; Zink A
    Arthritis Res Ther; 2016 Jun; 18():149. PubMed ID: 27338263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.